DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Journey Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$5.17+0.21 (+4.13%)
Close on Oct 19, 2026
- Market cap
- $142.14M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Journey Medical has not reported a dividend
No dividend per share appears in Journey Medical's annual filings since fiscal 2019.